Matica Bio opens CGT plant, with a little help from G-CON and Sartorius

Date Published05/09/2022
Author NameDan Stanton
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Parent companyMatica Biotechnology
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2022
Domestically, the work will be done:In-house
Country(ies) from which reshored:Korea, Republic of
City reshored to:College Station
State(s) reshored to:TX
If relevant, work nearshored to:-
Product(s) reshoredcell, gene therapy
What domestic positive factors made reshoring more attractive?Skilled workforce availability/training
Find Reshoring Articles